Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…
Read More
GSK Secures Promising Metabolic Oligonucleotide Therapy Rights from SiranBio in Up to $1 Billion Deal
In a significant move to bolster its pipeline and solidify its strategic focus on the complex challenges of obesity, global…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A recent population-based study, published in CANCER, a prestigious journal of the American Cancer Society, has brought to light a…
Read More
The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising Alternatives
Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More
Madrigal Pharmaceuticals Secures Global Rights to Arrowhead’s siRNA Asset for MASH, Paving Way for Combination Therapy Exploration
Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting LSD1 and GSK3 Enzymes
In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have identified a promising new therapeutic strategy to…
Read More
LEO Pharma Acquires Gene Therapy Pioneer Replay to Revolutionize Treatment for Rare Genetic Dermatological Diseases
In a landmark move poised to redefine the landscape of dermatological therapeutics, LEO Pharma, a global leader in medical dermatology,…
Read More
Creating early career opportunities for advanced therapy manufacturing and development
The RESILIENCE Skills program, a comprehensive UK-wide initiative, is actively addressing a critical talent deficit in advanced medicines manufacturing, a…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…
Read More
Regeneron cuts White House pricing deal, offers new gene therapy for free – Pharmaceutical Technology
Regeneron Pharmaceuticals has entered into a significant drug pricing agreement with the White House, marking a pivotal moment in the…
Read More
